伊管 ITRI 深 滬
已收盤 08-15 16:00:00 美东时间
126.28
+0.910
+0.73%
華盛通- 最 高126.68
- 今 開125.45
- 成交量 41.55万股
- 最 低 124.555
- 昨 收 125.37
- 總市值 57.57亿
- 52周最高 140.04
- 市盈率 靜 24.39
- 換手率 0.00%
- 52周最低 90.11
- 委 比 -54.85%
- 總股本 4558.81万
- 歷史最高 140.04
- 量 比 0.97
- 振 幅 1.69%
- 歷史最低 26.90
- 每 手 1
- 風險率 15.64%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Itron Appoints Sheri Savage to Board of Directors
Itron ( ($ITRI) ) has issued an update. On August 11, 2025, Itron, Inc. appoint...
08-15 04:48
美股大行评级 | 罕见！Meta、微软连续获多家大行上调目标价；花旗上调Robinhood目标价升至120美元
今日重点评级关注：丰业银行：维持Arcellx"跑赢大市"评级，目标价从93美元升至133美元；RBC Capital：维持Precision Drilling"跑赢大市"评级，目标价从89美元升至100美元
08-01 10:17
JP Morgan Upgrades Itron to Overweight, Raises Price Target to $145
JP Morgan analyst Mark Strouse upgrades Itron (NASDAQ:ITRI) from Neutral to Overweight and raises the price target from $128 to $145.
08-01 06:03
Itron shares are trading lower after the company reported a Q2 sales miss, issued Q3 sales guidance below estimates, and cut its FY25 sales guidance.
Itron shares are trading lower after the company reported a Q2 sales miss, issu...
08-01 01:54
Itron Raises FY2025 Adj EPS Guidance from $5.20-$5.60 to $6.00-$6.20 vs $5.43 Est; Lowers FY2025 Sales Guidance from $2.40B-$2.50B to $2.35B-$2.40B vs $2.46B Est
Itron (NASDAQ:ITRI) raises FY2025 Adj EPS guidance from $5.20-$5.60 to $6.00-$6.20 vs $5.43 analyst estimate. Lowers FY2025 sales outlook from $2.40 billion-$2.50 billion to $2.35 billion-$2.40 billion vs $2.46 billion
07-31 20:34
Itron Q2 Adj. EPS $1.62 Beats $1.33 Estimate, Sales $607.00M Miss $609.36M Estimate
Itron (NASDAQ:ITRI) reported quarterly earnings of $1.62 per share which beat the analyst consensus estimate of $1.33 by 21.62 percent. This is a 33.88 percent increase over earnings of $1.21 per share from the same
07-31 20:32
Earnings Scheduled For July 31, 2025
Companies Reporting Before The Bell • Vanguard Extended Duration Treasury ETF (...
07-31 16:32
Here are the major earnings before the open Thursday
Major earnings expected before the bell on Thursday include: AbbVie (OTC:ABBY) Bristol-Myers Squibb Company (BMY) Mastercard Incorporated (MA) CVS Health Corporation (CVS) Shell plc (SHEL) Other earni...
07-31 06:00
美股大行评级 | 丰业银行上调Meta目标价从525美元升至675美元；恩智浦获"超配"评级，目标价从190美元升至220美元
今日重点评级关注：瑞杰金融：维持Antero Resources Corp."强烈买入"评级，目标价从57美元升至58美元；美银证券：维持和黄医药"买入"评级，目标价从27美元升至28美元
07-23 09:42
JP Morgan Maintains Neutral on Itron, Raises Price Target to $128
JP Morgan analyst Mark Strouse maintains Itron (NASDAQ:ITRI) with a Neutral and raises the price target from $118 to $128.
07-22 19:47
